Haemophilus Somnus, 10555;Haemophilus Somnus, 8025

Verify with FDA CVM →

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
13
Deaths Reported
9290.0%
Death Rate

Active Ingredients

Haemophilus Somnus, 10555;Haemophilus Somnus, 8025

Administration Routes

Subcutaneous

Species Affected

Cattle 14

Most Affected Breeds

Mixed (Cattle) 10
Aberdeen Angus 3
Simmental 1

Most Reported Reactions

Death 13
Lack of efficacy - NOS 8
INEFFECTIVE, ANTIBIOTIC 2
Staggering 1
CULTURE/TITER DATA ABNORMAL 1
Lack of efficacy (virus) - NOS 1
Bronchopneumonia 1
Lack of efficacy (bacteria) - NOS 1
Weight loss 1
Malaise 1
Downer animal 1
Loose stool 1

Outcome Breakdown

Died
13 (56.5%)
Outcome Unknown
10 (43.5%)

Data Summary

Metric Value
Total adverse event reports 14
Reports involving death 13
Case-fatality rate (reported events) 9290.0%
Distinct species in reports 1
Distinct breeds in reports 3
Distinct reactions reported 13
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Haemophilus Somnus, 10555;Haemophilus Somnus, 8025 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 14 adverse event reports referencing Haemophilus Somnus, 10555;Haemophilus Somnus, 8025, including 13 reports in which the animal died — a 9290.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Haemophilus Somnus, 10555;Haemophilus Somnus, 8025. Reported administration route is Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Haemophilus Somnus, 10555;Haemophilus Somnus, 8025 reports are Cattle (14 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (10), Aberdeen Angus (3), Simmental (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Haemophilus Somnus, 10555;Haemophilus Somnus, 8025 are Death (13), Lack of efficacy - NOS (8), INEFFECTIVE, ANTIBIOTIC (2), Staggering (1). Of the 23 reports with a coded outcome, Died is the leading category at 56.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Haemophilus Somnus, 10555;Haemophilus Somnus, 8025.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial